CHOP 团队发现 MAP2K4 变异相关神经发育综合征并揭示 JNK 通路机制
Researchers identify role of newly discovered genetic variant in neurodevelopmental disorder
美国费城儿童医院(CHOP)团队在《American Journal of Human Genetics》报告,MAP2K4 基因新发变异与一类神经发育综合征相关,9 名新发变异患者及 1 名遗传方式不明患者出现发育迟缓、癫痫和先天畸形。
研究把 MAP2K4 变异与一类神经发育综合征联系起来,为不明原因儿童遗传病的诊断补充了候选基因。
Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the mechanisms of previously unknown changes in a gene that result in symptoms associated with a neurodevelopmental disorder. The findings underscore the importance of a critical pathway and its role in brain development. The findings were published in the American Journal of Human Genetics.
MAP2K4 is an enzyme that activates the c-Jun N-terminal kinase (JNK) pathway, an essential pathway for human neurodevelopment. While several prior studies have demonstrated that a loss in MAP2K4 is associated with multiple types of cancer, variants in the gene that produces the enzyme have not been linked to disease.
However, other genes linked to the JNK pathway have been associated with genetic disorders, and the gene has been linked as a potential cause of neurodevelopmental disorders.
In this study, researchers identified nine patients with de novo MAP2K4 variants—meaning that the variant was not inherited from either parent—and one additional patient with a MAP2K4 variant of unknown inheritance. These patients exhibited several symptoms associated with a neurodevelopmental disorder, including developmental delay, epilepsy and congenital malformations.
"As a pediatric clinical geneticist and researcher, it's always been important to me for every child to learn what their diagnosis is," said first study author Tomoki Nomakuchi, M.D., Ph.D., an attending physician with the Division of Genetic and Genomic Medicine at CHOP.
"Only half of children with a suspected genetic syndrome get an answer even with our best technology, and every time we discover a new syndrome, that's a few more families to have the door opened to better prognosis, research opportunities and, eventually, targeted treatments."
Beyond simply identifying the patients, the researchers wanted to understand the mechanisms taking place at a molecular level that result in these symptoms. The study team developed CRISPR-edited induced pluripotent stem cell-derived neurons with MAP2K4 deficiency, providing a platform for pathological modeling and preclinical testing to understand this novel disorder.
These stem cells revealed a variety of negative effects on the JNK pathway, providing a better understanding of the pathway's role in healthy neurodevelopment and a potential therapeutic target for further study.
"Neurodegenerative diseases such as Parkinson's and Alzheimer's diseases have implicated the JNK pathway, which, when adding the findings of this study, underscores the remarkable importance of this pathway across the life span," said co-senior author Elizabeth Bhoj, M.D., Ph.D., an attending physician in the Division of Genetic and Genomic Medicine at CHOP.
"While more preclinical work is needed to truly understand and appreciate the role MAP2K4 may have in neurodevelopmental disorders, these findings represent the first critical steps necessary toward identifying and potentially treating this previously unknown patient community."
Publication details
Tomoki T. Nomakuchi et al., De novo MAP2K4 variants cause a neurodevelopmental syndrome and impaired JNK signaling in iPSC-derived neurons, The American Journal of Human Genetics (2026). DOI: 10.1016/j.ajhg.2026.09.014
Journal information: American Journal of Human Genetics
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Researchers identify role of newly discovered genetic variant in neurodevelopmental disorder (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-role-newly-genetic-variant-neurodevelopmental.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com